Relugolix vs. Leuprolide Effects on Castration Resistance-Free Survival from the Phase 3 HERO Study in Men with Advanced Prostate Cancer

SIMPLE SUMMARY: An advanced prostate cancer research study known as HERO compared the ability of the medications relugolix and leuprolide to lower testosterone. The goal was to lower the testosterone to sustained castration levels, which is defined as below 50 ng/dL. This analysis evaluated how long...

Descripción completa

Detalles Bibliográficos
Autores principales: Saad, Fred, George, Daniel J., Cookson, Michael S., Saltzstein, Daniel R., Tutrone, Ronald, Bossi, Alberto, Brown, Bruce, Selby, Bryan, Lu, Sophia, Tombal, Bertrand, Shore, Neal D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571668/
https://www.ncbi.nlm.nih.gov/pubmed/37835548
http://dx.doi.org/10.3390/cancers15194854

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571668/
https://www.ncbi.nlm.nih.gov/pubmed/37835548
http://dx.doi.org/10.3390/cancers15194854

Ejemplares similares